USA - engelsk - NLM (National Library of Medicine)

akorn operating company llc - cimetidine hydrochloride (unii: wf10491673) (cimetidine - unii:80061l1wgd) - cimetidine 300 mg in 5 ml - cimetidine hydrochloride oral solution is indicated in: (1) short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration-duodenal ulcer). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. (2) maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg h.s. for periods of up to 5 years. (3) short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. (4) erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated for 12 weeks for hea

USA - engelsk - NLM (National Library of Medicine)

akorn - cimetidine hydrochloride (unii: wf10491673) (cimetidine - unii:80061l1wgd) - cimetidine hydrochloride oral solution is indicated in: (1) short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration-duodenal ulcer). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. (2) maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg h.s. for periods of up to 5 years. (3) short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. (4) erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated for 12 weeks for hea

USA - engelsk - NLM (National Library of Medicine)

morton grove pharmaceuticals, inc. - cimetidine hydrochloride (unii: wf10491673) (cimetidine - unii:80061l1wgd) - cimetidine 300 mg in 5 ml

USA - engelsk - NLM (National Library of Medicine)

pharmaceutical associates, inc. - cimetidine hydrochloride (unii: wf10491673) (cimetidine - unii:80061l1wgd) - cimetidine hydrochloride oral solution is indicated in: (1) short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration-duodenal ulcer). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. (2) maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg h.s. for periods of up to 5 years. (3) short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. (4) erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated for 12 weeks for hea

USA - engelsk - NLM (National Library of Medicine)

hospira, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - injection, solution - 6 mg in 1 ml - cimetidine hydrochloride injection is indicated in: (1) short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration − duodenal ulcer). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. (2) maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg h.s. for periods of up to five years. (3) short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. (4) prevention of upper gastrointestinal bleeding in critically ill patients. (5) the treatment of pathological hypersecretory conditions

USA - engelsk - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 400 mg - cimetidine tablets usp are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. - short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. - erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indic

USA - engelsk - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 300 mg - cimetidine tablets usp are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. - short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. - erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated for 12 weeks for healing of

USA - engelsk - NLM (National Library of Medicine)

blenheim pharmacal, inc. - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 300 mg - cimetidine tablets are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. - short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. - erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated

USA - engelsk - NLM (National Library of Medicine)

proficient rx lp - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 400 mg - cimetidine tablets are indicated in: cimetidine is contraindicated for patients known to have hypersensitivity to the product.

USA - engelsk - NLM (National Library of Medicine)

aidarex pharmaceuticals llc - cimetidine (unii: 80061l1wgd) (cimetidine - unii:80061l1wgd) - cimetidine 400 mg - cimetidine tablets are indicated in: - short-term treatment of active duodenal ulcer. most patients heal within 4 weeks and there is rarely reason to use cimetidine at full dosage for longer than 6 to 8 weeks (see dosage and administration , duodenal ulcer ). concomitant antacids should be given as needed for relief of pain. however, simultaneous administration of oral cimetidine and antacids is not recommended, since antacids have been reported to interfere with the absorption of oral cimetidine. - maintenance therapy for duodenal ulcer patients at reduced dosage after healing of active ulcer. patients have been maintained on continued treatment with cimetidine 400 mg at bedtime for periods of up to five years. - short-term treatment of active benign gastric ulcer. there is no information concerning usefulness of treatment periods of longer than 8 weeks. - erosive gastroesophageal reflux disease (gerd). erosive esophagitis diagnosed by endoscopy. treatment is indicated for 12 weeks for healing of les